The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.
Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.
Study Type
OBSERVATIONAL
Enrollment
50
We will utilize thromboelastography to discern when to transfuse blood products in the setting of multi-level spinal fusion
Laboratory analysis to guide transfusion
Mayo Clinic
Scottsdale, Arizona, United States
Estimated Blood Loss
Amount of blood loss measured in units of cc(mL)
Time frame: post operative approximately 1 day
Volume of transfused packed red blood cells
Amount of transfused packed red blood cells measured in units of cc(mL)
Time frame: post operative approximately 1 day
Adverse Events
Number of adverse events reported
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.